Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THYB-04 tuberculosis vaccine trial in healthy adolescents
PACTR201403000646306Phase 2Completed
- Sponsor
- Statens Serum Institut
- Start
- Aug 2012
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of tuberculosis vaccine and Placebo-COD Research Private Ltd in Tuberculosis (TB) (2 arms), sponsored by Statens Serum Institut. Primary endpoints: Safety and Interferon-gamma immune response. Started Aug 2012; status: completed.
02
Drugs
tuberculosis vaccinePlacebo-COD Research Private Ltd
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on PACTR201403000646306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201403000646306.